UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 241

Sortiert nach

Adding Rigor to Biomarker Evaluations-EDRN Experience

Cancer epidemiology, biomarkers & prevention, 2020-12, Vol.29 (12), p.2575-2582

2020

Link zum Volltext

Verfügbarkeit prüfen

Problems With Risk Reclassification Methods for Evaluating Prediction Models

American journal of epidemiology, 2011-06, Vol.173 (11), p.1327-1335

PEPE, Margaret S

2011

Link zum Volltext

Verfügbarkeit prüfen

Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study

BMJ (Online), 2017-06, Vol.357, p.j2813

2017

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic concordance among pathologists interpreting breast biopsy specimens

JAMA : the journal of the American Medical Association, 2015-03, Vol.313 (11), p.1122

2015

Link zum Volltext

Verfügbarkeit prüfen

Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design

JNCI : Journal of the National Cancer Institute, 2008-10, Vol.100 (20), p.1432-1438

2008

Link zum Volltext

Verfügbarkeit prüfen

Assessing the value of risk predictions by using risk stratification tables

Annals of internal medicine, 2008-11, Vol.149 (10), p.751

2008

Link zum Volltext

Verfügbarkeit prüfen

Net Reclassification Indices for Evaluating Risk Prediction Instruments: A Critical Review

Epidemiology (Cambridge, Mass.), 2014-01, Vol.25 (1), p.114-121

2014

Link zum Volltext

Verfügbarkeit prüfen

Estimation and Comparison of Receiver Operating Characteristic Curves

The Stata journal, 2009-03, Vol.9 (1), p.1-16

2009

Link zum Volltext

Verfügbarkeit prüfen

Net Risk Reclassification P Values: Valid or Misleading?

JNCI : Journal of the National Cancer Institute, 2014-04, Vol.106 (4), p.dju041

2014

Link zum Volltext

Verfügbarkeit prüfen

Statistical inference for net benefit measures in biomarker validation studies

Biometrics, 2020-09, Vol.76 (3), p.843-852

2020

Link zum Volltext

Verfügbarkeit prüfen

Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?

Clinical chemistry (Baltimore, Md.), 2016-05, Vol.62 (5), p.737-742

2016

Link zum Volltext

Verfügbarkeit prüfen

The Net Reclassification Index (NRI): A Misleading Measure of Prediction Improvement Even with Independent Test Data Sets

Statistics in biosciences, 2015-10, Vol.7 (2), p.282-295

2015

Link zum Volltext

Verfügbarkeit prüfen

Adjusting for Covariates in Studies of Diagnostic, Screening, or Prognostic Markers: An Old Concept in a New Setting

American journal of epidemiology, 2008-07, Vol.168 (1), p.89-97

2008

Link zum Volltext

Verfügbarkeit prüfen

Improving the quality of biomarker discovery research: the right samples and enough of them

Cancer epidemiology, biomarkers & prevention, 2015-06, Vol.24 (6), p.944-950

2015

Link zum Volltext

Verfügbarkeit prüfen

When does combining markers improve classification performance and what are implications for practice?

Statistics in medicine, 2013-05, Vol.32 (11), p.1877-1892

2013

Link zum Volltext

Verfügbarkeit prüfen

Measuring the performance of markers for guiding treatment decisions

Annals of internal medicine, 2011-02, Vol.154 (4), p.253

2011

Link zum Volltext

Verfügbarkeit prüfen

Does the net reclassification improvement help us evaluate models and markers?

Annals of internal medicine, 2014-01, Vol.160 (2), p.136

2014

Link zum Volltext

Verfügbarkeit prüfen

Time-Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker

Biometrics, 2000-06, Vol.56 (2), p.337-344

2000

Link zum Volltext

Verfügbarkeit prüfen

Combining biomarkers by maximizing the true positive rate for a fixed false positive rate

Biometrical journal, 2021-08, Vol.63 (6), p.1223-1240

2021

Link zum Volltext

Verfügbarkeit prüfen

Partial AUC Estimation and Regression

Biometrics, 2003-09, Vol.59 (3), p.614-623

2003

Link zum Volltext

Verfügbarkeit prüfen

Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve

Biometrika, 2009-06, Vol.96 (2), p.371-382

2009

Link zum Volltext

Verfügbarkeit prüfen

A Framework for Evaluating Markers Used to Select Patient Treatment

Medical decision making, 2014-02, Vol.34 (2), p.159-167

2014

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the Predictiveness of a Continuous Marker

Biometrics, 2007-12, Vol.63 (4), p.1181-1188

2007

Link zum Volltext

Verfügbarkeit prüfen

Integrating the Predictiveness of a Marker with Its Performance as a Classifier

American journal of epidemiology, 2008-02, Vol.167 (3), p.362-368

2008

Link zum Volltext

Verfügbarkeit prüfen

Designing a study to evaluate the benefit of a biomarker for selecting patient treatment

Statistics in medicine, 2015-11, Vol.34 (27), p.3503-3515

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(221)
Mit Volltextzugriff
(205)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(165)
Life Sciences & Biomedicine
(149)
Humans
(134)
Mathematics
(74)
Physical Sciences
(69)
Statistics & Probability
(68)
Female
(56)
Mathematical & Computational Biology
(55)
Biological And Medical Sciences
(54)
Medical Sciences
(53)
Male
(43)
Risk Factors
(40)
Roc Curve
(40)
Biomarkers
(39)
Public, Environmental & Occupational Health
(39)
Models, Statistical
(38)
Adult
(34)
Statistics
(31)
Regression Analysis
(28)
Predictive Value Of Tests
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Adding Rigor to Biomarker Evaluations-EDRN Experience

Problems With Risk Reclassification Methods for Evaluating Prediction Models

Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study

Diagnostic concordance among pathologists interpreting breast biopsy specimens

Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design

Assessing the value of risk predictions by using risk stratification tables

Net Reclassification Indices for Evaluating Risk Prediction Instruments: A Critical Review

Estimation and Comparison of Receiver Operating Characteristic Curves

Net Risk Reclassification P Values: Valid or Misleading?

Statistical inference for net benefit measures in biomarker validation studies

Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?

The Net Reclassification Index (NRI): A Misleading Measure of Prediction Improvement Even with Independent Test Data Sets

Adjusting for Covariates in Studies of Diagnostic, Screening, or Prognostic Markers: An Old Concept in a New Setting

Improving the quality of biomarker discovery research: the right samples and enough of them

When does combining markers improve classification performance and what are implications for practice?

Measuring the performance of markers for guiding treatment decisions

Does the net reclassification improvement help us evaluate models and markers?

Time-Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker

Combining biomarkers by maximizing the true positive rate for a fixed false positive rate

Partial AUC Estimation and Regression

Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve

A Framework for Evaluating Markers Used to Select Patient Treatment

Evaluating the Predictiveness of a Continuous Marker

Integrating the Predictiveness of a Marker with Its Performance as a Classifier

Designing a study to evaluate the benefit of a biomarker for selecting patient treatment

Suchergebnisse filtern